PIC/S 2023-2027 Strategic Plan(2022년도 발표자료)입니다(첨부 참조하세요)

The Pharmaceutical Inspection Co-operation Scheme (PIC/S) was established in 1995 as an extension to the Pharmaceutical Inspection Convention (PIC) of 1970 (see Annex). PIC/S is a legally non-binding co-operative arrangement between Regulatory Authorities in the field of Good Manufacturing Practice (GMP) of medicinal products for human or veterinary use. It is open to any Authority having a comparable GMP inspection system. On 31 December 2021, PIC/S comprised 54 Participating Authorities (PAs) from all continents. PIC/S strives to improve public health by leading development and implementation of inspection frameworks for human and veterinary medicines through harmonisation of standards and offering world class training to regulatory inspectors around the globe. This is achieved by harmonising inspection procedures worldwide, by developing common standards in the field of GMP, by providing training opportunities to inspectors and by facilitating co-operation and networking between competent authorities, regional and international organisations, thus increasing confidence, inspection reliance and avoiding duplication of efforts as well as wasting of resources. A Committee of the Participating Authority representatives (the PIC/S Committee) supervises the operation of the Scheme. All decisions are taken unanimously. The Committee is assisted in its task by (i) various Sub-Committees; (ii) an Executive Bureau, which steers the Organisation in-between meetings; and (iii) a Secretariat, which supports PIC/S bodies in their duties. This is the PIC/S 2023-2027 Strategic Plan.